Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CYCLOSPORINE
- Drug Nephrotoxicity Amelioration by N-acetylcysteine
- CyFluATG in Lower Risk MDS
- Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.
- Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement
- RY_SW01 Cell Injection Therapy in Active Lupus Nephritis
- Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly
- Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis
- Improving Drop Instillation Comfort of a Cyclosporine A Solution
- A Clinical Study of MIL62 in Primary Membranous Nephropathy
- Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy
- A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults
- Phase II Clinical Trial to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops in Patients With Dry Eye Disease
- Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis
- Avatrombopag Combined With IST as First-line Treatment for SAA
- Semaglutide Treatment for Hyperglycaemia After Renal Transplantation
- Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients
- Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery
- Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy
- Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia
- Comparison Between Topical Mitomycin C and Cyclosporine
- Safety, Tolerability and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
- A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
- A Phase II Pediatric Study of a Graft-VS.-Host Disease (GVHD) Prophylaxis Regimen With no Calcineurin Inhibitors After Day +60 Post First Allogeneic Hematopoietic Cell Transplant for Hematological Malignancies
- Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD- An RCT
- A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
- Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver Function
- Assessment of Rituximab Therapeutic Response Versus Conventional Treatment
- Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the Elderly
- Clinical Course and Treatment of Ligneous Conjunctivitis in Children With Plasminogen Deficiency
- A Clinical Study of MIL62 in Primary Membranous Nephropathy
- Letermovir in ART-treated HIV-infected Persons
- Comparison of Two Types of Artificial Tears
- Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
- Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum
- DEgenerative ROtator Cuff Disease and Botulinum TOXin: a Randomized Trial
- A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
- Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
- Herbal Medication to Treat Dry Eye in Peri/ Post-menopausal Women
- Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma
- Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment
- Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult Participants
- AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
- A Feasibility Study to Evaluate the Tolerability of Oph1 Compared to Restasis in Healthy Volunteers
- The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases
- Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
- A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine
- Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD
- Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) 20 mcg/mL vs Vehicle, in Patients With Sjogren's Dry Eye
- Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye
- Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis
- A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults
- Second-line Treatment of Primary Autoimmune Hemolytic Anemia
- Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable
- Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD
- The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia
- Cyclosporine vs Steroids in DRESS
- Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital
- ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT
- The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients
- An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis
- Outcomes of Patients After Allo-HSCT With Decitabine and NAC
- Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response
- Leflunomide for Musculoskeletal GVHD After Allogeneic Stem Cell Transplant
- Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% on Application of PROSE Devices for Management of Patients With Ocular Surface Disease
- Comparison of Safety and Efficacy of de Novo Everolimus
- Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood
- Rescue Therapy With the Human Anti-CD38 Antibody MOR202 (Felzartamab) in Patients With Membranous Nephropathy Who Failed Anti-CD20 Target Therapy
- Methods of T Cell Depletion Trial (MoTD)
- NMF-CsA-Dupi Trial
- Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998)
- Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™
- CEQUA for Sjogren's Syndrome Dry Eye
- Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells
- Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery
- Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients
- Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome
- A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING)
- Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN
- Novel Use of Restasis and PROSE Devices
- Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
- Topical Cyclosporine A for the Treatment of Dry Eye: A Randomized Clinical Study
- Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis
- Topical Immuonosuppressant Drugs in Spring Catarrh
- Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"
- MSC for Treatment of cGVHD After Allo-HSCT
- From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy
- PCSK 9 Inhibition as Secondary Prevention in Renal Transplant Patients
- A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
- Topical Cyclosporine-A for Management of Epiphora
- GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide
- Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis
- Lipid Management in Renal Transplant Recipients Using Evolocumab.
- Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19
- Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial
- Comparing Treatment of Dry Eye With Intracanlicular Dexamethasone, Restasis, and/or Lotemax
- Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects
- Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia
- Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers
- Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
- Tear Film Markers in Dry Eye Syndrome
- Cyclosporine For The Treatment Of COVID-19(+)
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
- Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA
- Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19
- Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
- TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL
- Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis
- The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.
- The Effect of Cyclosporin Before Cataract Surgery
- Cyclosporine in Patients With Moderate COVID-19
- Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19
- Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis
- CLAG-M Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
- Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.
- Effect of Cequa™ in Subjects With Dry Eye Disease
- Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
- Sirolimus Combined With ATRA for the Treatment of Auto-Immune Anemia
- Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- Effect of Oral Zinc Supplementation as an Adjuvant to Topical Corticosteroid in Oral Lichen Planus Patients
- Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants
- Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD
- Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days
- Drug Interaction Study of the Effect on Cyclosporine on Ozanimod and Major Active Metabolites
- Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients
- PDE5i Use in Renal Transplant Recipients
- A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplant
- Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical Trial
- Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence
- Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome
- A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor
- Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients
- Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata
- Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia
- A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia:
- Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
- Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome
- A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
- Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
- An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)
- Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
- Esomeprazole or Pantoprazole in Renal Transplantation
- Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin
- A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults
- Autologous Plasma Treatment for Severe Dry Eye Patients
- PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
- Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7
- Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects
- Dupilumab in Chronic Spontaneous Urticaria
- Investigation of Flare and Remission in Subjects With Atopic Dermatitis
- Efavirenz for Patients With Alzheimer's Disease
- Hepatitis C Positive Donor Into Hepatitis C Negative Recipients
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye
- A Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A Inhalation Solution in the Treatment of CLAD/Bronchiolitis Obliterans Syndrome in Patients Post Single Lung Transplant
- A Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A Inhalation Solution in the Treatment of CLAD/Bronchiolitis Obliterans Syndrome in Patients Post Double Lung Transplant
- Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery
- Comparison Between Rebamipide 2% Versus Autologous Serum
- Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Tacrolimus Treatment for Refractory PRCA
- Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation
- HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis
- Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
- A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisa
- An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants
- Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA
- Corneal Tear Film Imaging of the Cornea Before and After Restasis Therapy
- Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation
- CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML
- CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AML
- Sirolimus Treatment for Refractory PRCA
- Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients
- Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC
- Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease
- To Assess and Compare the Efficacy of Cyclosporine Versus Azathioprine in the Treatment of Chronic Refractory Urticaria
- Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation
- Eltrombopag in Children With Idiopathic Aplastic Anemia
- Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole
- Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis
- Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy
- Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of Psoriasis
- Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients
- A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions
- 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
- Drug/Drug Interactions With F901318
- Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus
- Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia
- Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema
- A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia
- Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia
- NATIENS: Optimal Management and Mechanisms of SJS/TEN
- Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
- Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDS
- Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide
- A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen
- Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day.
- A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis
- The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes Mellitus
- Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.
- Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients at 3 Years of Follow-up. CIRCUS II Study
- Cyclosporine A Pretreatment and Kidney Graft Function
- Macitentan in the Treatment of Organ Rejection After Lung Transplantation
- CYclosporine A in Shockable Out-of-hospital Cardiac Arrest ResUScitation
- Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT
- Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Topical Solution for the Treatment of Atopic Dermatitis
- SCHEDULE Follow Up Visit 5-7 yr
- Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
- ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia
- Prevention of Irinotecan Induced Diarrhea by Probiotics
- Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation
- Parkinsonian Brain Repair Using Human Stem Cells
- Treatment of Macrophage Activation Syndrome (MAS) With Anakinra
- HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen
- StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies
- Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
- A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable
- The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia
- Copenhagen Acute Renal Complications After Transplantations Study Group
- Evaluation of Local Doxycycline in Smokers With Chronic Periodontitis
- Allogeneic Stem Cell Transplantation for Children With CML
- Cyclosporine Plus Methotrexate or Alemtuzumab
- Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
- Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Re
- Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).
- Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantati
- Comparison Study of Psoriasis Severity Assessment Tools
- A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors
- Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia
- Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis
- Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
- Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids
- Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant
- Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A
- Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients
- Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease
- Bioavailability of Paracetamol, Amoxicillin and Talinolol Before, Immediately and One Year After Gastric Bypass Operation
- Liver Immunosuppression Free Trial
- Traumatic Brain Injury and Effects of Acute Cyclosporine A
- The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant Recipients
- Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease
- Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome
- Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes
- The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea
- Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on Lichen Planus
- Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia
- Influence of Aliskiren on Albuminuria After Kidney Transplantation
- HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
- Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients
- CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma
- Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografte
- Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects
- L-leucine in Diamond Blackfan Anemia Patients
- Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
- Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues
- Belimumab in Idiopathic Inflammatory Myositis
- Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)
- Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major
- Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic A
- ESTEROID WITHDRAWAL STUDY, SAFETY AND EFFICACY IN RENAL TRANPLANTATION
- Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI Donors
- Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects
- Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects
- Drug-Drug Interaction Study in Healthy Adult Volunteers
- A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule
- Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease
- Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis
- Cyclosporine A in Patients With Small Diameter Abdominal Aortic Aneurysms
- Belatacept 3 Month Post Transplant Conversion Study
- Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
- Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection
- A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia
- The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular Surface
- Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer
- Intra-Osseous Co-Transplant of UCB and hMSC
- Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic Neuropathy
- Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)
- Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients
- Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
- Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT
- HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects
- Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
- Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy Procedure
- Clinical Trial Using Humira in Netherton Syndrome
- CyclASol® Phase 1 Study
- Hepatitis C in Renal Transplant Recipients
- hATG+CsA vs hATG+CsA+Eltrombopag for SAA
- A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.
- Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients
- SRL (Sirolimus) Withdrawal
- Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring
- Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions
- A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients
- A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus
- Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
- OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
- Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
- Everolimus Post Orthotopic Liver Transplant
- Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia
- Preemptive Therapy of GVHD
- Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
- Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients
- Comparing Everolimus and Sirolimus in Renal Transplant Recipients
- Methotrexate in the Treatment of Chronic Idiopathic Urticaria
- Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma
- Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309)
- A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transpl
- Belatacept Therapy for the Failing Renal Allograft
- Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
- Role of Everolimus in Highly Sensitized Patients
- Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock
- Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome
- Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Extended Dosing With Eltrombopag for Severe Aplastic Anemia
- Bortezomib in Late Antibody-mediated Kidney Transplant Rejection
- Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis
- Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops
- Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B
- Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function
- EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety
- A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based
- Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients
- Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)
- Kidney Graft Function Under the Immunosuppression Strategies
- Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
- Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
- Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients
- Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS
- Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy
- Anakinra for Inflammatory Pustular Skin Diseases
- Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients
- Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
- Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease
- Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas
- Antibiotics and Hydroxychloroquine in Crohn's
- Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
- the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient
- Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma
- The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes
- The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)
- Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease
- Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis
- Abatacept as GVHD Prophylaxis Phase 2
- Belatacept Early Steroid Withdrawal Trial
- A Study to Assess the Effects of Cyclosporine on the Pharmacokinetics and Safety of Canagliflozin (JNJ-28431754) in Healthy Volunteers
- Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation
- Islet Allotransplantation in Type 1 Diabetes
- Anti-IL-5 Therapy in Bullous Pemphigoid (BP)
- The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients
- Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%
- Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria
- A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy
- Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
- A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers
- Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
- CYCLosporinE A in Reperfused Acute Myocardial Infarction
- Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients
- Buprenorphine Disposition and Cyclosporine
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria
- Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic Sclerosis
- Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
- Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
- Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids
- Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.
- Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)
- Cyclosporine A in Cardiac Arrest
- Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
- Nephroprotective Effects of Carnitine and (PDE5) Inhibitor Agent Against Contrast Media-induced Nephropathy (CMN)
- A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
- Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
- A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy Volunteers
- The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes (T2DM)
- Study to Assess Effect of Cyclosporine on the Blood Levels of Ticagrelor
- 90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients
- Drug-Drug Interaction Study With Pravastatin and Cyclosporine
- Drug Interaction Study of Isavuconazole and Cyclosporine
- A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus
- Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients
- Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation
- Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection
- Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine.
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma
- Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation
- Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
- Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate
- Everolimus in de Novo Kidney Transplant Recipients
- Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
- Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)
- Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)
- Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.
- Single Dose Study Of The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Health Volunteers
- Extended Follow-Up After Islet Transplantation in T1D
- Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis
- Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
- Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Search for Transcriptional Biomarkers in a Conversion Protocol From Calcineurin Inhibitors to Mycophenolate Mofetil
- Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye
- Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS
- Clinical Trial Treatment in Lupus Nephritis
- A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil).
- Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant
- Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment
- Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome
- Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML
- Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients
- Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
- Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation
- Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood
- Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
- SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance
- Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
- Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant
- Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
- Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies
- High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy
- Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation
- Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia
- Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
- Telmisartan Versus Losartan in Kidney Transplantation
- Thymus Transplantation Safety-Efficacy
- Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients
- Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda
- Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
- Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
- A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
- MEmbranous Nephropathy Trial Of Rituximab
- High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma
- Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies
- Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
- Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis
- Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft Recipients
- Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy
- Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients
- Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia
- Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD)
- Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)
- A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
- Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis
- Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome
- Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]
- Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium
- Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
- Dry Eye Assessment and Management: Feasibility Study
- Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Bioequivalence Study of Cyclosporine 100mg Capsule Under Fed Condition
- Bioequivalence Study of Cyclosporine 100mg Capsule Under Fasting Condition
- Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients
- Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
- Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)
- A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
- Topical Cyclosporine Suspension for the Treatment of Brittle Nails
- Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
- Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
- Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease
- Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus
- A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults
- Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer
- Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection Episodes
- mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation
- Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.
- CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation
- Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
- Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
- Rapamycin and Regulatory T Cells in Kidney Transplantation
- Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
- Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by Cardiopulmonary Bypass
- Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation
- Pentostatin, Cyclophosphamide Plus Rituximab (PCR) for the Therapy of Poor-Prognosis Chronic Graft-Versus-Host Disease
- Mini Allo Stem Cell Transplantation for the Treatment of Solid Tumors
- Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation
- Study of Cyclosporine in Post-LASIK Patients
- Trial of Cyclosporine for Myocardial Protection During Open Heart Surgery
- Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
- Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis
- Drug-Drug Interaction Study Between Colchicine and Cyclosporine
- A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity
- Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer
- Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease
- Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)
- Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).
- Pilot Trial of Statin Use in Burn Patients
- Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study
- Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
- Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
- Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant
- Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia
- A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
- Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation
- Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment
- Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus Post Kidney Transplant: The Myfortic Study
- Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
- CIS001 Extension Study of Cyclosporine Inhalation Solution
- Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation
- Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
- Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
- Ciclosporin in the Management of New Type 1 Reactions in Leprosy
- Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum
- Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
- Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant Patients
- Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma
- Optima: Optimizing Prograf Therapy in Maintenance Allografts II
- Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation
- Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
- Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders
- Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
- Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal
- Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure
- Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
- Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis
- Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.
- A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients
- A Phase I Open-Label Study of the Effects of Tacrolimus and Cyclosporine on CP-690,555 in Healthy Volunteers
- Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine
- Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation
- Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
- Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes
- Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation
- Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
- Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
- Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
- Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel
- Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation
- Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients
- Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy Volunteers
- Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
- Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant Patients
- Calcineurin Free Immunosuppression in Renal Transplant Recipients
- Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients
- Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
- Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
- Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
- Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant
- Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)
- Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies
- Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
- Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
- A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.
- Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus
- Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)
- Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal Transplantation
- Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants
- Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
- Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen
- Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma
- Diabetogenicity of Cyclosporine and Tacrolimus
- Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
- Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
- Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders
- TRUST Study: Raptiva ® in Hand & Foot Psoriasis
- NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
- A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation
- Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis
- Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
- Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease
- Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
- Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic
- Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)
- Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol
- Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction
- Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes
- ChangE From Any Systemic psoriasiS therapY to Raptiva
- Total Marrow Irradiation for Refractory Acute Leukemia
- Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis
- Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)
- Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes
- Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients
- Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
- Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
- Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant
- Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
- Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation
- Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)
- MD Ezetimibe Cyclosporine Interaction (0653-057)
- PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients
- Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes
- Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)
- Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
- Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients
- Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients
- Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
- Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
- Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer
- A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
- Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers
- Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
- Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
- Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
- Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors
- Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients
- Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
- Photopheresis for the Treatment of Acute Graft Versus Host Disease
- Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)
- A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy
- Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up
- In-Vivo Activated T-Cell Depletion to Prevent GVHD
- Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State
- Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Rel
- Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation
- Phase I/II Thymus Transplantation With Immunosuppression #950
- Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease
- Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
- Topical Cyclosporine and Disease Progression
- Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
- Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients
- Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria
- The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye
- Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia
- Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
- Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
- Rituximab Treatment of Focal Segmental Glomerulosclerosis
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
- Study of Four Different Chemotherapy Regimens With or Without Total-Body Irradiation Followed by Umbilical Cord Blood Transplant in Treating Patients With Relapsed or Refractory Hematologic Cancer
- Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
- Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis
- Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function
- Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients
- Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
- Safety of ON 01910.Na in Patients With Myelodysplasia
- This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.
- This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus
- Interaction Between Rimonabant and Cyclosporine and Tacrolimus
- Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease
- Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS
- Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
- Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus
- Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD)
- Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen
- Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
- A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure
- Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus
- Safe Renal Function In Long Term Heart Transplanted Patients
- Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients
- Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
- High Dose Cyclophosphamide for Treatment of Scleroderma
- MMF vs. AZA for Kidney Transplantation
- Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria
- Fibrosis in Renal Allografts
- Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome
- Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients
- Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT
- Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
- Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects
- Study Evaluating Rapamune® Maintenance Regimen
- Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients
- Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients
- Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients
- Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia
- Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient
- Nitrate and Hypertension in Heart Transplanted Patients
- Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty
- Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk
- Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant Patients
- Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis
- Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
- Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients
- Safety and Efficacy Study of CF101 to Treat Psoriasis
- Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients
- Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia
- Donor Stem Cell Transplantation for Congenital Immunodeficiencies
- Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
- Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
- HSP-glomerulonephritis Trial: MP vs CyA
- Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.
- Shift to Everolimus (RAD) Kidney Sparing Study
- Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients
- Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML
- Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients
- Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)
- Thymoglobulin (ATG) Dose Finding Study
- Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients
- Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
- Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms
- Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?
- Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis
- A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids
- Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.
- Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
- Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
- Alefacept for Chronic Graft Versus Host Disease
- Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
- Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
- Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
- Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome
- Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
- The Effectiveness of Lower Cyclosporine Doses for Psoriasis
- Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
- Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease
- Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
- SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus
- Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
- Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia
- Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome
- Alefacept for Prevention of Graft Versus Host Disease (GVHD)
- Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation
- Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation
- Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
- Fluphenazine Decanoate for Psoriasis
- Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
- Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant
- Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
- A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis
- Pilot Study for HLA Identical Living Donor Renal Transplant Recipients
- A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease
- Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
- Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies
- Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant
- An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.
- Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia
- A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients
- Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
- Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis
- Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.
- A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients
- Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC)
- Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
- Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
- Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
- Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia
- Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases
- Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma
- Simultaneous Pancreas-kidney Transplantation With Campath Protocol
- Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients
- Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
- Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
- Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation
- Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF)
- Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS
- Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
- To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN
- Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis
- Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
- Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer
- Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
- Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection
- Myfortic - Treatment for Extensive cGvHD
- Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation
- Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
- CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation
- Rituximab in the Treatment of Patients With Bullous Pemphigoid
- Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Patients
- MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive
- Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism
- Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia
- Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
- Efalizumab to Treat Uveitis
- Aerosol Cyclosporine for Prevention of Lung Rejection
- Immunopharmacological Effects of Rituximab in Atopic Dermatitis
- Metabolic Pattern of Cyclosporine A and Acute Renal Failure
- Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
- Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus
- A 36-Week Extension to Protocol ISA04-03
- Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
- Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
- Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients
- G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
- Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients
- Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients
- Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
- Randomized Placebo-Controlled Study of ISA247 in Plaque Psoriasis
- Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
- Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients
- Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
- Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients
- Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids,
- An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients
- Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids
- Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.
- Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients
- Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants
- Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation
- MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus
- MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients
- Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
- Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
- IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
- G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome
- Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients
- To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning
- Efalizumab for Moderate to Severe Atopic Dermatitis
- Polymorphism of the Cytochrome P450-system in Renal Transplants
- A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
- A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
- MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal
- A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation
- Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients
- Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis
- Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation
- Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation
- Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation
- Problems With Morphine Use in Patients With a Severe Brain Injury
- Alemtuzumab to Treat Severe Aplastic Anemia
- Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus
- Study Evaluating Sirolimus in Kidney Transplant Recipients
- Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans
- Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
- Allogeneic Transplantation From Related Haploidentical Donors
- Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies
- Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma
- The Vienna Prograf and Endothelial Progenitor Cell Study
- Stem Cell Transplant for Hemoglobinopathy
- Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients
- Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant
- Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients
- Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients
- Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant
- Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients
- Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients
- Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.
- Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids
- Study Evaluating Sirolimus in Kidney Transplant Recipients.
- Alefacept in Patients With Severe Scalp Alopecia Areata
- Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
- The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients
- Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
- Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy
- Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens
- Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients
- Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients
- A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.
- Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)
- Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients
- Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels
- Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion
- Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients
- Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids
- Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302
- Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant
- Transitioning From Cyclosporine to Alefacept in Psoriasis
- Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)
- The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease
- Effects of Cyclosporine A on Pancreatic Insulin Secretion
- Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation
- Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk
- Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients
- Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)
- Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation
- Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation
- Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation
- Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients
- Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)
- Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndr
- Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia
- Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
- Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
- Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
- Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors
- Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
- Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma
- Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia
- Etanercept for Treatment of Hidradenitis
- Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
- Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Cyclosporine Implant for Ocular Graft-Versus-Host Disease
- Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy
- Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant
- Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia
- Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
- Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant
- Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
- Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia
- Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
- Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
- Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV
- OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
- T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies
- Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer
- Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
- Daclizumab and Sirolimus to Treat Uveitis
- Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers
- Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Metastatic Breast Cancer
- A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
- Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
- Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
- Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
- Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
- S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
- Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia
- Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
- Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients
- Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
- Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
- Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia
- Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia
- Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma
- Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
- Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
- Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease
- Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
- S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
- Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
- To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris
- Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
- A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation
- A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients
- Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
- Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
- Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas
- Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis
- Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
- Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies
- Sirolimus for Focal Segmental Glomerulosclerosis
- Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients
- Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, D
- Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney
- Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
- Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
- Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission
- Increasing HAART-Induced Immune Restoration With Cyclosporine
- Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
- Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
- Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
- Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis
- Herb-Opioid Interactions
- Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS
- Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma
- Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome
- Steroid Withdrawal in Pediatric Kidney Transplant Recipients
- Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care
- Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia
- Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
- Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
- Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia
- S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
- Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia
- Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
- Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
- Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission
- Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders
- Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
- Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
- Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
- Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- Kidney Transplant for HIV-Infected Patients in Renal Failure
- Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
- Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
- Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
- Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk My
- Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma
- Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
- Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer
- Bone Marrow Transplantation in Treating Patients With Leukemia
- Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer
- Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma
- Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
- Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection
- Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders
- Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
- Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
- Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy
- Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
- Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission
- Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia
- Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia
- Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia
- S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
- Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
- Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer
- Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma
- Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
- Bone Marrow Transplant in Treating Patients With Hematologic Cancers
- Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
- A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
- Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
- Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
- Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia
- Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome
- Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
- Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
- Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
- Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
- Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
- Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
- Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
- Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
- Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
- Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
- Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
- Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
- Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
- High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma
- Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
- Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia
- Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia
- Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
- Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
- Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant
- Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia
- Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
- Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
- Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
- Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission
- Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation
- Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)
- Combination Therapy of Severe Aplastic Anemia
- A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
- Leflunomide to Treat Uveitis
- A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
- Medical Treatment for Diamond Blackfan Anemia
- Cyclosporin Implant to Treat Uveitis
- Comparing Therapies for the Treatment of Severe Aplastic Anemia
- Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
- A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833
- A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833
- A Study To Test An Anti-Rejection Therapy After Kidney Transplantation
- A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease
- Myocarditis Treatment Trial
Clinical trials list
click for details